<DOC>
<DOCNO>
EP-0011591
</DOCNO>
<TEXT>
<DATE>
19800528
</DATE>
<IPC-CLASSIFICATIONS>
A61P-25/02 C07C-69/732 C07D-319/12 A61K-31/5585 C07D-319/00 A61P-7/02 <main>C07C-177/00</main> C07C-401/00 C07C-59/00 C07C-45/00 A61P-7/00 C07C-45/67 C07C-67/00 C07C-62/32 C07C-45/59 C07C-51/347 C07C-51/353 C07C-51/00 C07C-59/46 C07C-62/00 C07D-317/00 C07C-405/00 C07D-317/72 A61K-31/5575 A61P-25/00 C07C-69/00 C07D-309/12 C07D-309/00 C07C-45/71 A61K-31/557 A61P-43/00 C07C-67/343 
</IPC-CLASSIFICATIONS>
<TITLE>
prostane derivatives, their production and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
schering agde<sep>schering aktiengesellschaft berlin und bergkamen<sep>schering aktiengesellschaftd-13342 berlinde <sep>schering aktiengesellschaft berlin und bergkamen<sep>
</APPLICANT>
<INVENTOR>
casals jorge dr  <sep>losert wolfgang prof<sep>mannesmann gerda dr<sep>raduchel bernd dr<sep>skuballa werner dr<sep>vorbruggen helmut prof<sep>casals, jorge, dr.<sep>losert, wolfgang, prof.<sep>mannesmann, gerda, dr.<sep>raduchel, bernd, dr.<sep>skuballa, werner, dr.<sep>vorbruggen, helmut, prof.<sep>casals, jorge, dr.wichernstrasse 20d-1000 berlin 33de<sep>losert, wolfgang, prof.niedstrasse 12d-1000 berlin 41de<sep>mannesmann, gerda, dr.hagenplatz 3ed-1000 berlin 33de<sep>radüchel, bernd, dr.gollanczstrasse 132d-1000 berlin 28de<sep>skuballa, werner, dr.olwenstrasse 25d-1000 berlin 28de<sep>vorbrüggen, helmut, prof.wilkestrasse 7d-1000 berlin 27de<sep>casals, jorge, dr.  <sep>losert, wolfgang, prof.<sep>mannesmann, gerda, dr.<sep>raduchel, bernd, dr.<sep>skuballa, werner, dr.<sep>vorbruggen, helmut, prof.<sep>casals, jorge, dr.wichernstrasse 20d-1000 berlin 33de<sep>losert, wolfgang, prof.niedstrasse 12d-1000 berlin 41de<sep>mannesmann, gerda, dr.hagenplatz 3ed-1000 berlin 33de<sep>radüchel, bernd, dr.gollanczstrasse 132d-1000 berlin 28de<sep>skuballa, werner, dr.olwenstrasse 25d-1000 berlin 28de<sep>vorbrüggen, helmut, prof.wilkestrasse 7d-1000 berlin 27de<sep>
</INVENTOR>
<ABSTRACT>
The new prostant derivatives-of the formula wherein R₁ may mean hydrogen, alkyl, cycloalkyl, aryl or a heterocy cliche residue, a one -CH₂-CH₂-, trans -CH = CH or -C≡C group, W a free or functional modified hydroxymes of thylene group or a free or functionally modified group, wherein the OH group is α-under / or β-constantly, d and e together a direct bond or D is a straight-chain or branched saturated or unacitated alkylene group with 1-10 c Atoms, which is given by fluorine atoms, E is an oxygen atom or a -C≡C binding or a direct binding, R₂ an alkyl, cycloalkyl, or an optionally substained aryl or a heterocyclic group, R₃ is a free or Functionally modified hydroxy group, and if R₁ has the meaning of a hydrogen atom whose salts mean with physiologically acceptable bases, e.g. b. 5- (E) - (1S, 5S, 6R, 7R) -7 -7-hydroxy-6- [(E) -3α-hydroxy-1-octenyl] -bicyclo [3. 3. 0] Octan-3-ylidene-3 pentanic acid, have hypotensive and bronchodilatori properties and can therefore be used as a pharmaceuticals. You can also u. a. to inhize the thrombocyte aggregation, for the prophylaxis and therapy of the heart attack and for the treatment of stroke. Their preparation by a Wittig reaction is described.
</ABSTRACT>
</TEXT>
</DOC>
